dimethylphenylpiperazinium iodide has been researched along with Heart Failure in 1 studies
Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bibevski, S | 1 |
| Dunlap, ME | 1 |
1 other study available for dimethylphenylpiperazinium iodide and Heart Failure
| Article | Year |
|---|---|
Prevention of diminished parasympathetic control of the heart in experimental heart failure.
Topics: Animals; Dimethylphenylpiperazinium Iodide; Dogs; Heart; Heart Failure; Male; Nicotinic Agonists; Pa | 2004 |